This inventor holds 2 USPTO granted patents. Top assignee: Novartis Ag. Active years: 2001-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2005
Title: The Innovations of Christiane Toupet
Introduction
Christiane Toupet is a notable inventor based in Mulhouse, France. She has made significant contributions to the field of biotechnology, particularly in the area of antibiotic biosynthesis. With a total of 2 patents to her name, her work has implications for both medical and industrial applications.
Latest Patents
One of her latest patents focuses on the "Rifamycin biosynthesis gene cluster." This invention primarily relates to a DNA fragment obtainable from the gene cluster responsible for rifamycin biosynthesis within the genome. It comprises at least one gene or a part of a gene that codes for a polypeptide involved in the biosynthesis of rifamycin. The patent also includes a method for preparing said DNA fragment, as well as recombinant DNA molecules that comprise one of the DNA fragments according to the invention. Additionally, it covers plasmids and vectors derived from this DNA, along with host organisms transformed with said plasmid or vector DNA. Another significant patent pertains to "Staurosporin biosynthesis gene clusters," further showcasing her expertise in genetic engineering.
Career Highlights
Christiane Toupet is currently employed at Novartis AG, a leading global healthcare company. Her role involves extensive research and development in the field of pharmaceuticals, where she applies her innovative ideas to create new solutions for health challenges.
Collaborations
Throughout her career, Christiane has collaborated with several esteemed colleagues, including Thomas Schupp and Nathalie Engel. These partnerships have allowed her to enhance her research and contribute to groundbreaking advancements in biotechnology.
Conclusion
Christiane Toupet's work exemplifies the intersection of innovation and biotechnology. Her patents not only advance scientific knowledge but also hold the potential for significant impact in the medical field. Her contributions continue to inspire future research and development in antibiotic biosynthesis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile